Related Experiment Video
Updated: Jun 14, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Genetic background influences mitochondrial function: modeling mitochondrial disease for therapeutic development.
Paule Bénit1, Riyad El-Khoury, Manuel Schiff
1Inserm, U676, Paris, 75019, France.
Genetic background significantly impacts human mitochondrial disease phenotypes. Preserving genetic diversity in animal models is crucial for accurately studying disease expression and evaluating potential drug therapies.
Area of Science:
- Genetics
- Mitochondrial Biology
- Disease Modeling
Background:
- Human mitochondrial diseases exhibit significant phenotypic variability due to complex genetic interactions.
- Mitochondrial function relies on approximately 1500 nuclear genes, creating numerous points for genetic influence on disease.
- Establishing clinical trial cohorts for rare mitochondrial diseases is challenging due to patient numbers and variability.
Purpose of the Study:
- To highlight the critical role of genetic background in shaping mitochondrial disease phenotypes.
- To emphasize the necessity of genetic diversity in animal models for accurate disease and therapeutic studies.
- To advocate for the preservation of genetic diversity in preclinical research for mitochondrial disorders.
Main Methods:
- Analysis of data from diverse animal models of mitochondrial diseases.
- Comparison of disease phenotypes across different genetic backgrounds within these models.
- Evaluation of the impact of genetic diversity on the utility of animal models for therapeutic research.
Main Results:
- Many existing animal models display attenuated or absent disease phenotypes compared to human patients.
- Insufficient genetic diversity in animal models can mask the influence of genetic background on disease severity.
- Lack of genetic diversity limits the translatability of findings from animal models to human mitochondrial diseases.
Conclusions:
- Genetic diversity is essential for developing and utilizing animal models that accurately reflect human mitochondrial disease phenotypes.
- Future research and therapeutic studies for mitochondrial diseases must incorporate greater genetic diversity in preclinical models.
- Attention to genetic background in model systems is key to advancing our understanding and treatment of mitochondrial disorders.
Related Concept Videos
Animal Mitochondrial Genetics
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondria
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenomics: Identification of New Drug Targets
Mitochondrial Membranes

